Monthly Archives November 28, 2018

Research Summary: Understanding treatment decisions from the perspective of people with relapsing remitting multiple sclerosis: A critical interpretive synthesis The past decade has seen a number of new...

Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we discussed the potential role of Epstein-Barr Virus or EBV in...

"It is intriguing...can you modulate the gut microbiome to improve outcomes in MS, such as reducing relapse rates? That would be a fabulous end goal!" - Prof Helen Tremlett. The potential role of the gut...